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Uncontrolled endoplasmic reticulum (ER) stress responses are proposed to contribute to the pathology of chronic inﬂammatory
diseases such as type 2 diabetes or atherosclerosis. However, the connection between ER stress and inﬂammation remains
largely unexplored. Here, we show that ER stress causes activation of the NLRP3 inﬂammasome, with subsequent release of the
pro-inﬂammatory cytokine interleukin-1b. This ER-triggered proinﬂammatory signal shares the same requirement for reactive
oxygen species production and potassium efﬂux compared with other known NLRP3 inﬂammasome activators, but is
independent of the classical unfolded protein response (UPR). We thus propose that the NLRP3 inﬂammasome senses and
respondstoERstressdownstreamofapreviouslyuncharacterizedERstressresponsesignalingpathwaydistinctfromtheUPR,
thus providing mechanistic insight to the link between ER stress and chronic inﬂammatory diseases.
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Inﬂammation is the ﬁrst response of the immune system to
infection or tissue injury, and is meant to protect the body from
these insults. Prolonged or chronic inﬂammation, however,
can exacerbate tissue damage and is implicated in the
development of diseases, such as arthritis, neurodegenera-
tive diseases and type 2 diabetes.
1 The endoplasmic
reticulum (ER) stress response is a potent, evolutionarily
conserved response to misfolded proteins and cellular
metabolic stress. The inﬂammatory response is frequently
triggered as a consequence of ER stress, caused by
metabolic problems or by the accumulation of misfolded
proteins.
2Undersuchconditions,theERinitiatestheunfolded
protein response (UPR). This response is initially aimed at
altering the cellular transcriptional and translational programs
toresolvetheprotein-foldingdefect,butiftheproblempersists
it initiates programed cell death. In addition to the intracellular
responses, chronic ER stress can also, by mechanisms that
remain poorly characterized, cause inﬂammation within
affected tissues.
3
Recent years have seen remarkable growth in our
understanding of the cellular and molecular mechanisms
that control the inﬂammatory response. In particular, proteins
belonging to the NOD-like receptor (NLR) family have
been identiﬁed as central players in innate immunity.
4,5
Some of these NLRs participate in multiprotein complexes
termed inﬂammasomes, which mediate caspase-1-depen-
dent maturation of the highly proinﬂammatory cytokine
interleukin-1b (IL-1b). Of the thus far described inﬂamma-
somes, the NLRP3 inﬂammasome is most fully character-
ized.
6 In addition to microbial and viral danger
signals (PAMPs), the NLRP3 inﬂammasome is unique
in that it can sense the presence of endogenous danger
signals that are associated with cellular or tissue damage
or stress (DAMPs), such as uric acid crystals.
4 As the
mechanism by which ER stress triggers inﬂammation
remains poorly understood, we sought to investigate the role
of the NLRP3 inﬂammasome as a potential sensor of ER
stress.
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We ﬁrst determined whether induction of ER stress triggers
the maturation of IL-1b. Human macrophages were exposed
to tunicamycin, an inhibitor of GlcNAc-1-phosphate transfer-
ase and thus of glycoprotein synthesis, in order to induce ER
stress. The presence of processed IL-1b was detected in the
supernatant of the human monocytic cell line THP-1 and
primary human monocytes – macrophages following stimula-
tion with tunicamycin (Figures 1a and b). Similarly, induction
of ER stress using Brefeldin A (BFA), which reversibly blocks
protein transport from the ER to the Golgi, also caused IL-1b
maturation and secretion. (Figures 1a and b). Thapsigargin,
which induces ER stress by blocking ER SERCA pumps and
therebydepleting ER Ca
2þ stores, also led to IL-1b secretion,
although exclusively in primary cells (Figure 1a and data not
shown). Taken together, these data suggest that induction of
ER stress by three different compounds results in the release
of mature IL-1b by human macrophages.
The NLRP3 inﬂammasome is composed of NLRP3,
Cardinal, the adaptor ASC and caspase-1, and mediates the
production of active IL-1b in response to an ever-expanding
list of stimuli.
4 A second inﬂammasome is constituted of the
NLR member NLRC4 and caspase-1, and senses the PAMP
ﬂagellin, while a third inﬂammasome senses DNA via AIM2.
While all inﬂammasomes described thus far (the NLRP3,
AIM2, NLRC4 and NLRP1 inﬂammasomes) sense various
PAMPs, only the NLRP3 inﬂammasome has been shown to
respond to a plethora of DAMPs as well. We therefore
hypothesized that NLRP3 is the inﬂammasome sensor
activated by ER stress.
To conﬁrm the speciﬁc involvement of the NLRP3 inﬂam-
masome, we induced ER stress in THP-1 cells in which
NLRP3, ASC and caspase-1 were knocked-down using
shRNA. We found that secretion of IL-1b was markedly
reduced in cells deﬁcient in NLRP3, ASC and caspase-1, but
not NLRC4 (Supplementary Figure 1, and data not shown).
The speciﬁc involvement of the NLRP3 inﬂammasome was
further conﬁrmed by performing similar experiments in murine
macrophages isolated from Nlrp3
 / , Asc
 /  or Nlrc4
 /  mice
(Figures 2a–c). Moreover, ER stress-induced inﬂammasome
activation is independent of toll-like or RIG-I-like receptors,
as IL-1b secretion was normal in MyD88-, Trif- and
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Figure 1 ER stress triggers the release of mature interleukin-1b by
macrophages. (a) PMA-differentiated THP-1 cells were stimulated with uric acid
crystals (MSU, positive control), BFA, thapsigargin or tunicamycin for 6h.
Precipitated supernatant and whole-cell extracts were then analyzed by western
blot. (b) Human primary macrophages were stimulated with MSU, BFA
or tunicamycin for 6h, and analyzed by western blot. IL-b, mature IL-1b; pIL-1b,
proIL-1b; Casp1, mature caspase-1; pCasp1, procaspase-1; SN, supernatant;
xT, whole-cell extract
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Figure 2 ER stress speciﬁcallyactivates theNLRP3 inﬂammasome. (a–c) LPS-primed bone marrow-derived macrophagesfrom Nlrp3
þ/þ, Nlrp3
 / , Asc
þ/þ, Asc
 / ,
Nlrc4
þ/þ and Nlrc4
 /  mice, respectively, were stimulated with MSU, tunicamycin, thapsigargin or BFA as indicated for 6h, and analyzed by western blot
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Cell Death and DiseaseMavs-deﬁcient murine macrophages (Supplementary Figures
2A, B and C).
The mechanism by which the NLRP3 inﬂammasome is
activated remains unclear,
7,8 though recent evidence sug-
gests mitochondria sense and integrate various danger
signals and relay the signal to the NLRP3 inﬂammasome.
9
Nonetheless, both potassium (K
þ) efﬂux and an increase of
reactive oxygen species (ROS) are required for NLRP3
inﬂammasome activation in response to all stimuli tested thus
far. We therefore examined whether these factors are
required for ER stress-induced IL-1b maturation. This was
indeed the case as the addition of ROS scavengers
(Figure3a)ortheinhibitionofK
þ efﬂux(Figure3b)completely
inhibited IL-1b secretion. Additionally, cytochalasin D treat-
ment, which blocks actin polymerization, failed to block ER
stress-induced IL-1b secretion, suggesting that phagocytosis
is not required akin to other non-particulate NLRP3 agonists
(Figure 3c).
The ﬁnding that ER stress, like other NLRP3 activators,
activates the NLRP3 inﬂammasome in a K
þ efﬂux- and ROS-
dependent manner suggests that it may also be sensed by
mitochondria. Thus, it is conceivable that ER stress initiates a
signal that is transmitted to mitochondria and then relayed to
the NLRP3 inﬂammasome. This notion is consistent with the
subcellular localization of NLRP3. In resting cells, NLRP3 is
associated with ER membranes, and then upon activation
translocates to membranes that are positive for markers
of both ER and mitochondria, which likely correspond to
mitochondria-associated membranes (MAMs).
9
VDACs are the major channels for the exchange of
metabolites and ions between the mitochondria and other
cellular compartments, including the ER. They are therefore
important for mitochondrial oxidative metabolism and the
generation of ROS. We therefore tested whether dampening
mitochondrial activity by knocking down the expression of
VDACs has an impact on inﬂammasome activation induced
by ER stress. Akin to MSU, inﬂammasome activation by
tunicamycin was impaired in cells with downregulated VDAC1
(Figure 3d). Interestingly, VDAC2 knock-down did not affect
IL-1b secretion by tunicamycin, while it substantially
decreased inﬂammasome activity triggered by MSU or other
NLRP3 activators, as previously reported (Figure 4a and data
not shown).
9 This intriguing observation suggests the
existence of different inﬂammasome activation mechanisms
downstream of ER stress compared with other known NLRP3
activators, possibly at the mitochondrial level.
The cellular response to ER stress results in the activation
of the UPR, which consists of the three main effector
pathways that are initiated by ER-localized transmembrane
proteins, namely IRE1a, PERK and ATF6a. We thus
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Figure 3 Mechanism of ER stress-induced inﬂammasome activation is similar to that of other known NLRP3 activators. (a, b and c) PMA-differentiated THP-1 cells were
pre-incubated for 30min with 50-mM ammonium pyrrolidinedithiocarbamate, 130-mM extracellular KCl or 2-mM cytochalasin D (Cyto D), respectively, stimulated with MSU,
R837or tunicamycin for a further6h, andanalyzedbywestern blot.(d) PMA-differentiatedTHP-1cells overexpressing an anti-VDAC1, anti-VDAC2orscramble shRNAwere
stimulated with MSU or tunicamycin for 6h, and analyzed by western blot
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Cell Death and Diseaseinvestigated the possible role of UPR effectors in inﬂamma-
some activation. THP-1 cells stably expressing shRNA
against IRE1a or PERK displayed no alteration in the
secretion of mature IL-1b in response to BFA or tunicamycin
treatment (Figures 4a and b and Supplementary Figure 3).
Additionally, macrophages derived from Atf6a
 /  mice did not
differ from WT littermates in their response to thapsigargin or
tunicamycin(Figure4c).Ofnote,strongNLRP3activators like
MSU or R837 did not induce CHOP upregulation (Figure 4a),
suggesting that they do not induce ER stress and their ability
to activate the inﬂammasome is thus also independent of an
ER stress response.
The UPR results in widespread blockage of the translation
of most proteins through phosphorylation of eIF2a. Simulta-
neously,it selectivelyinducesthe transcriptionandtranslation
of proteins initially involved in pro-survival pathways to help
the cell cope with and resolve the cause of ER stress, and
subsequently to initiate programed cell death if the ER stress
is excessive or prolonged. Overall, most downstream
effectors of the UPR are thus transcription-dependent.
While synthesis of the ER stress response effector CHOP
was blocked by the transcriptional inhibitor actinomycin D,
inﬂammasome activation was not affected (Figure 4d). This
observation further suggests that activation of the NLRP3
inﬂammasome by ER stress is not dependent on the UPR.
Assignaling pathwaystriggeredbythe UPRappearedtobe
dispensable, we next investigated the role of alternative
signaling pathways that were shown to emanate from a
stressed ER.
2 ER stress is proposed to trigger NF-kB
activation through the interaction between IRE1a and the
IKK complex via the adaptor TRAF2.
10,11 In line with the
observation that IRE1a is not required (see above), THP-1
cells expressing an shRNA against TRAF2 responded
normally to NLRP3 agonists (Supplementary Figure 4a).
We next investigated a possible role of the JNK signaling
pathway. ER stress-induced JNK activation is thought to be
triggeredbyaTRAF2-andASK1-(astress-activatedMAP3K)
dependent pathway. However, neither TRAF2 nor ASK1 were
required for inﬂammasome activation in response to ER
stress, as both THP-1 cells with knock-downed TRAF2
and macrophages from Ask1
 /  mice responded normally
(Supplementary Figures 4A and B).
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In this study, we demonstrated that three different com-
pounds (BFA, tunicamycin and thapsigargin), that are known
toinduceERstress,alsoactivatetheNLRP3inﬂammasomein
human and murine macrophages. The activation mechanism
is similar to that of other known NLRP3 activators, requiring
ROS generation and potassium efﬂux. A minor observed
discrepancy lies in the VDAC1, but not VDAC2, requirement
for activation of the inﬂammasome by ER stressors, possibly
suggesting the existence of different signaling pathways
triggered by the various NLRP3 activators.
Interestingly, we could not ﬁnd a role for the well-known ER
stress effectors PERK, IRE1a or ATF6a in NLRP3 inﬂamma-
some activation. Consequently, we thus rule out the involve-
ment of the classical UPR in this signaling pathway, and
suggest that an UPR-independent ‘fourth branch’ of the ER
stress response regulates NLRP3 inﬂammasome activation.
As such, we do not offer deﬁnitive proof that ER stress per se
is responsible for NLRP3 inﬂammasome activation. Indeed,
it could be argued that BFA, tunicamycin and thapsigargin
could each have speciﬁc, ER-independent, inﬂammasome-
activating properties distinct from one another. However, in
keeping with Occam’s razor, we believe that the most
straightforward explanation is that a previously uncharacter-
ized response stemming from a stressed ER, that is distinct
from the UPR, is responsible for the ability of these
compounds to activate the inﬂammasome. The precise
signaling pathway involved remains elusive, similar to other
NLRP3 activators described to date.
Chronic inﬂammatory diseases such as diabetes and
atherosclerosis are linked to chronic metabolic dysregulation
and ER stress. ER membranes have long been known to
co-sediment with those from the metabolic hub of the cell,
namely mitochondria. These ER MAMs have a different
composition than the rest of the ER, giving rise to the concept
that they may have specialized functions. Interestingly, we
have previously shown that activation of the NLRP3 inﬂam-
masome occurs at the MAMs.
9 Mitochondria were recently
shown to have a pivotal role in activation of the inﬂamma-
some, and here we show that ER stress also activates the
inﬂammasome.
MAMs are known to regulate exchange of metabolites,
lipids and Ca
2þ between the ER and mitochondria. These
factors, as well as tight regulation of mitochondrial fusion and
ﬁssion, are critical for appropriate mitochondrial activity. We
thus propose a model in which ER stress alters steady-state
communication between the ER and mitochondria, leading to
dysregulated mitochondrial activity, enhanced production of
mitochondrial ROS and thus activation of the NLRP3
inﬂammasome. Our data suggest that this ER stress-induced
inﬂammasome activation is independent of the UPR
response. Apart from the UPR response, other signaling
pathways have been described to radiate from the ER or
mitochondriasuchastheactivationofJNKandNF-kB,bothof
which were not necessary for inﬂammasome activation.
Chronic ER stress is observed in obesity, and in cellular
systems ER stress leads to insulin resistance.
12 The
results presented here suggest that ER stress-induced
NLRP3 inﬂammasome activation may contribute to ER
stress-induced disease. This concept is supported by clinical
trials demonstrating an important role of IL-1b (and thus the
inﬂammasome) in the progression of T2D.
13 Blocking IL-1b or
IL-1R leads to an astonishing improvement of glucose and
insulin levels. Another example of a clinical evidence for a
connection between ER stress and the inﬂammasome
in chronic inﬂammatory disease comes from patients with
TNF-receptor-associated periodic syndrome (TRAPS).
14
TRAPS is similar to cryopyrin-associated periodic syndromes
(CAPS, caused by mutations in NLRP3), in that both diseases
are characterized by recurrent fevers, abdominal and joint
pain and myalgia, similar to symptoms found in CAPS
patients. While CAPS is caused by mutations in NLRP3,
TRAPS is caused by mutations in TNF-R1, which were
originally thought to cause altered shedding of the extra-
cellular portion of TNF-R1.
15 More recent ﬁndings, however,
suggest that the mutated TNF-R1 trafﬁcs abnormally and
accumulates in the ER.
14 Moreover, TRAPS-associated
TNF-R1mutantscauseenhancedproductionofmitochondrial
ROS,
14 which is a requirement for NLRP3 inﬂammasome
activation. It is therefore possible that accumulation of the
TNF-R1 in the ER triggers ER stress and mitochondrial
ROS production, thereby causing NLRP3 activation and
subsequent IL-1b release. This would explain the surprising
clinical ﬁnding that this classically TNF-driven disease can be
treated withIL-1inhibitors.
16 Considering thatthedynamicsof
ER–mitochondria interaction has a crucial role in NLRP3
inﬂammasome activation, targeting ER stress may, as
previously suggested,
3 represent an attractive therapeutic
target to combat chronic inﬂammatory disease.
Materials and Methods
Reagents. Uric acid, LPS, ammonium pyrrolidinedithiocarbamate, nigericin and
actinomycin D were purchased from (Sigma-Aldrich Chemie GmbH, Buchs,
Switzerland). BFA, tunicamycin, thapsigargin, puromycin, phorbol 12-myristate
13-acetate (PMA) were from Alexis (Enzo life Sciences (ELS) AG, Lausen,
Switzerland). Ultra-pure LPS was from Invivogen (LabForce AG, Nunningen,
Switzerland), and potassium chloride from AppliChem (Axon Lab AG,
Baden-Da ¨ttwil, Switzerland).
Antibodies. The primary antibodies used in this study were obtained from
Sigma-Aldrich (tubulin), Apotech (Enzo Life Sciences (ELS) AG) (NLRP3), MBL
(LabForce AG) (ASC), Cell Signaling (BioConcept, Allschwil, Switzerland) (human
mature IL-1b, BiP, PERK and VDAC1), Santa Cruz Biotechnology, Inc.
(Heidelberg, Germany) (human caspase-1 and IRE1a), Abcam plc (Cambridge
Science Park, UK) (VDAC2) and Alexis (CHOP). The antibody against mouse
caspase-1 (p20) is a generous gift from Dr Peter Vandenabeele (Ghent University).
The antibody against human pro-IL-1b was produced in-house while that
against mouse-IL-1b was a kind gift from Roberto Solari (GlaxoSmithKline AG,
Mu ¨nchenbuchsee, Switzerland). Primary antibodies were generally used at a
1:1000 dilution in blocking solution (PBS-0.05% Tween with 5% skim milk).
Generation of THP-1 cells stably expressing shRNA. THP-1 cells
stably expressing shRNA were obtained by lentiviral infection as previously
described.
17Plasmids encoding for shRNA against NLRP3, ASC and caspase-1
were homemade and have been described.
18 The other shRNA-encoding plasmids
werefromSigma,andtheirrespectivesequenceswereasfollows:IRE1a,5 0-CCGG
GAGAAGATGATTGCGATGGATCTCGAGATCCATCGCAATCATCTTCTCTTTTT-30;
MyD88, 50-CCGGGCAGAGCAAGGAATGTGACTTCTCGAGAAGTCACATTCCT
TGCTCTGCTTTTT-30; PERK, 50-CCGGCCGTAGTAAGAAATGGATCATCTCGA
GATGATCCATTTCTTACTACGGTTTTT-30; TRAF2, 50-CCGGCGAGACGGTAGA
GGGTGAGAACTCGAGTTCTCACCCTCTACCGTCTCGTTTTT-30 and 50-CCGGC
CCTTGCAGATTCCACGCCATCTCGAGATGGCGTGGAATCTGCAAGGGTTTTT-30;
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Cell Death and DiseaseVDAC1, 50-CCGGGCAGTTGGCTACAAGACTGATCTCGAGATCAGTCTTGTAG
CCAACTGCTTTTT-30; VDAC2, 50-CCGGGATCTCAACAAGAGCTGTATTCTCGA
GAATACAGCTCTTGTTGAGATCTTTTTTG-30.
Mice. Nlrp3
 / ,
19 Asc
 / ,
20 IPAF/Nlrc4
 / ,
20 Atf6a
 / 21 and Ask1
 /  22 mice
have been described. All mice were on C57BL/6 background and were housed at
theUniversityof LausannefollowingtheSwissFederalVeterinaryOfﬁceguidelines.
Cell preparation and stimulation. Human THP-1 cells were maintained in
RPMI 1640 medium (Invitrogen, Life Technologies Europe BV, Zug, Switzerland),
supplemented with 10% fetal calf serum (FCS, PAA Laboratories GmbH, Chemie
Brunschwig AG, Basel, Switzerland) and 1% penicillin–streptomycin (Invitrogen) at
371C and 5% CO2. For experiments, THP-1 cells were differentiated for 3h with
100-nM PMA on the day before stimulation. Primary murine bone marrow-derived
macrophages were isolated from tibial and femoral bone marrow progenitors as
described,
23 and primed with 100ng/ml ultra-pure LPS overnight the day
before stimulation. Human primary monocytes were isolated from whole blood
obtained from the Center for Blood Transfusion, Lausanne, Switzerland, using the
OptiPrep TM protocol (Axis-Shield AG, Wa ¨denswil, Switzerland) following
the manufacturer’s instructions. Cell extracts and precipitated supernatants were
analyzed by western blot.
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